Bayer seeks wider use for eye drug Eylea in Europe

German drugmaker Bayer said it filed for marketing approval in Europe for the use of eye drug Eylea as a treatment of diabetic macular oedema.

Bayer to challenge India`s ruling allowing cheaper cancer drug copy

India`s decision to allow the production of a cheaper generic copy of a patented cancer drug will be challenged by German drug maker Bayer.

`India patent ruling may open door for cheaper HIV drugs`

India`s move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments.